Intermediates, key starting materials or finished products, whether the active is a small molecule or large molecule or a peptide or even complex modalities such as cell therapy, gene therapy, are key elements of the pharmaceutical R&D value chain - the innovative, life-saving therapies that form the backbone of modern medicine.

If you are a contract research organization (CRO), a contract manufacturing organization (CMO), or a contract development and manufacturing organization (CDMO) supplying building blocks, key starting materials, advanced intermediates, small and large molecule API, therapeutic peptides, finished dosage forms, clinical trial materials, biological reagents, kits, cell lines, disease models, ... for biopharmaceutical research, we invite you to set up a store front at Atlantis AI360.

Please email us at partners@atlantisai360.com.